This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Prism Biolab Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yoichiro Hirose and His Work in Cancer-Related Drug Discovery.
Introduction
Yoichiro Hirose is an inventor associated with Prism Biolab Corporation in Kanagawa, Japan. His listed patent concerns heterocyclic compounds investigated for their potential to inhibit cancer cell proliferation.
Latest Patents
Hirose is credited with 1 patent: “Heterocyclic Compounds.” The patent describes a compound of formula (I), with its symbols defined in the description, or a pharmaceutically acceptable salt thereof. The disclosed compounds are reported to have superior inhibitory activity on cancer cell proliferation.
Career Highlights
Hirose’s listed patent work connects his name with pharmaceutical research focused on compounds that may inhibit cancer cell growth. The available information identifies Prism Biolab Corporation as his company.
Collaborations
Hirose’s listed coworkers include Hajime Takashima and Eiji Honda. Their names are associated with the same professional context provided for Hirose.
Conclusion
Yoichiro Hirose’s recorded invention centers on heterocyclic compounds with reported cancer-cell proliferation inhibitory activity, reflecting his connection to pharmaceutical innovation at Prism Biolab Corporation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile